Market research
AMED Amedisys Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- 39.3
- Analyst target
- 95.2
- Dividend yield
- Not available
- Beta
- 0.9
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- US0234361089
- Market cap
- 3B
- P/E ratio
- 39.3
- Analyst target
- 95.2
- Dividend yield
- Not available
- Beta
- 0.9
About
About Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AMED discussion.
5 years, 4 months ago
Amedisys, Inc is currently in a long term uptrend where the price is trading 1.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
Amedisys, Inc's total revenue rose by 10.0% to $551M since the same quarter in the previous year.
Its net income has increased by 63.3% to $45M since the same quarter in the previous year.
Finally, its free cash flow fell by 13.7% to $64M since the same quarter in the previous year.
Based on the above factors, Amedisys, Inc gets an overall score of 4/5.